JPT(薬理と治療)JPT Online RCT・過去の臨床試験論文より

---

Placebo-controlled double-blind study of recombinant growth hormone for adult patients with growth hormone deficiency

Late phase II study of sepimostat mesilate(FUT-187)in postgastrectomy reflux esophagitis −Clinical optimum dose in a double blind study−

Pharmacokinetic interaction between ampiroxicam and antiacid Phase I study of a new antianxiety drug,SC-48274 The phase I study of high moleculer weight sodium hyaluronate(NRD101), a new anti-arthritis agent

A phase I study of calcium mupirocin 2% nasal ointment −Safety and pharmacokinetic profile of mupirocin following nasal application in healthy male Japanese subjects− A phase I study of granisetron hydrochloride(1) −The safety of single oral administration in healthy Japanese subjects− Clinical Evaluation of RPY-005, a low molecular weight heparin, for extracorporeal circulation during hemodialysis in patients with chronic renal insufficiency −A double-blind cross-over comparative study with heparin− Phase I study of vamicamide(1) −Single-and multiple dose studies− Phase I study of vamicamide(2) −Single-and multiple dose studies− Safety tolerance and pharmacokinetics of milrinone in phase I study in healthy male apanese subjects(2) −After intravenous infusion− The effect of nizatidine on gastric emptying and plasma gastrin concentration in patients with peptic ulcer A phase 1 clinical study of EPOCH（epoetin beta） −A multiple subcutaneous does study−

Clinical study of triazolam on sleep disorders in psychiatric aspect −Comparative cross-over study with zopiclone− Evaluation of pharmacokinetics of sustained release formulation of bunazosin(E1015) compared to sugar-coated plain tavlets(Detantol )and effect of food on pharmacokinetics of E1015 Results of phase I multiple dose study with NB-818,a new calcium channel blocker Skin reactions to nitrate tapes at the early stage of application Ursodeoxycholic acid for chronic non-A,non-B hepatitis −A dose-response study−

Phase I Study（single administration）of CBM 36-733